Fridays @ 7:30 PM EST
How can investors curb car insurance costs?
'Barron's Roundtable' panel provides insight on the increased pressure on consumers.
What is the impact of weight-loss drugs on companies that make obesity treatments?
'Barron's Roundtable' panelists discuss the hefty cost of obesity drugs and its impact on Medicare benefits.
Stocks slump as Federal Reserve signals rates will remain elevated
'Barron's Roundtable' panelists discuss three things investors should be thinking about.
What does Federal Reserve's hawkish stance means for investors?
Cresset Capital CIO and founding partner Jack Ablin discusses higher interest rates and offers his market outlook on 'Barron's Roundtable.'
This is the time we see ‘more definitive’ issues pop up: Liz Young
Liz Young discusses how Wall Street is bracing for a September Fed rate decision on ‘Barron’s Roundtable.’
'Barron's Roundtable' discusses three things investors should be thinking about
FOX Business host Jack Otter and 'Barron's Roundtable' panelists offer their market outlook as the week comes to an end.
United Auto Workers strike is 'unprecedented': Al Root
Barron's senior writer Al Root joins 'Barron's' Roundtable' to discuss the impact of government incentives on electric vehicle sales growth and the UAW strike.
Banking got hit very hard this year: Carleton English
Panelists Ben Levisohn, Carleton English and Jack Hough discuss the financial industry on 'Barron's Roundtable.'
People have underestimated how strong the U.S. economy can be: Rick Rieder
BlackRock Global Fixed Income CIO Rick Rieder provides insight on the global economy on 'Barron's Roundtable.'
Why is September a terrible month for stocks?
Panelists Ben Levisohn, Carleton English and Jack Hough discuss the stock market, the threat of China and inflation on 'Barron's Roundtable.'
How can Warner Bros recover financially?
Jack Otter and ‘Barron’s Roundtable’ discuss the challenges still facing Warner Bros. after merge with Discovery.
These are the 3 things investors need to be thinking about right now
'Barron's Roundtable' panelists discuss the new iPhone, interest rates and more.
US is at an 'incredibility elevated' number of open jobs: Sébastien Page
T. Rowe Price's Sébastien Page reacts to the August jobs report on 'Barron's Roundtable.'
Jerome Powell's 'hawkish' speech reminds me of a 'Seinfeld' episode: Ed Yardeni
Yardeni Research president Ed Yardeni reacts to the Federal Reserve's inflation fight and potentially additional rate hikes on 'Barron's Roundtable.'
What went wrong with Monster's Q2 earnings?
Barron's stock pick writer Jacob Sonenshine provides insight on the energy drink company's success on 'Barron's Roundtable.'
Powell says the Fed will be data-dependent: Ben Levisohn
Panelists Ben Levisohn, Al Root and Andrew Bary provide insight on the Federal Reserve's moves on 'Barron's Roundtable.'
Finance expert breaks down what to look for in promising AI stocks
NYU Stern School of Business finance professor Aswath Damodaran breaks down the evaluation of Nvidia stock and where it is likely headed on 'Barron's Roundtable.'
Earnings growth stinks: Jack Hough
Panelists Jack Hough, Carleton English and Elizabeth O'Brien break down stock market performance on 'Barron's Roundtable.'
Oppenheimer effect gifts IMAX best July ever: 'No greater experience,' says CEO Richard Gelfond
IMAX CEO Richard Gelfond reacts to Oppenheimer's success and the impact blockbusters have on the movie industry on 'Barron's Roundtable.'
Could new obesity drugs have benefits other than weight loss?
Jack Hough and the panel discuss a new drug aimed at tackling obesity and the possible other benefits the drug may have on ‘Barron’s Roundtable.’